BCAB
USDBioAtla Inc. Common Stock
$0.673+0.023 (3.615%)
실시간 가격
Healthcare
생명공학
미국
가격 차트
Loading Chart...
핵심 지표
시장 지표
시가
$0.650
고가
$0.678
저가
$0.613
거래량
0.11M
기업 기본 정보
시가총액
39.5M
산업
생명공학
국가
United States
거래 통계
평균 거래량
1.01M
거래소
NCM
통화
USD
52주 범위
저가 $0.24현재가 $0.673고가 $2.525
관련 뉴스
GlobeNewswire
BioAtla Presents Compelling Mechanistic Rationale for Targeting ROR2 with Ozuriftamab Vedotin (Oz-V) in Oropharyngeal Squamous Cell Carcinoma (OPSCC) at the Annual Conference of the International Papillomavirus Society
SAN DIEGO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (NASDAQ:BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the
더 보기
GlobeNewswire
BioAtla to Present Clinical Data for Mecbotamab Vedotin (BA3011) in Soft Tissue Sarcoma at SITC 2025
SAN DIEGO, Oct. 03, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (NASDAQ:BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics using its
더 보기
